Organization: Health Canada
Year: 2021
Month: January
Request Number: A-2020-000646
Request Summary: Adverse Reaction Reports (AERs) for DEXILANT. Report numbers: E2B_03001390, E2B_03007028. ADR for DEXLANSOPRAZOLE: 000737824. ADRs for ENTYVIO: E2B_03031243, E2B_03046110, E2B_03046110, E2B_02992604. ADRs for IXAZOMIB: E2B_03024203, E2B_03038125. ADRs for VEDOLIZUMAB: E2B_03015043, E2B_03015151, E2B_03017623, E2B_03024509, E2B_03029828, E2B_03037893. ADR for ONDANSETRON: E2B_02992226, E2B_02992333. ADRs for PANTOLOC: E2B_02992556, E2B_03032452.
Disposition: Disclosed in part
Number of pages: 345